Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125736542 | 12573654 | 2 | F | 20160708 | 20160729 | 20160720 | 20160802 | EXP | PHHY2016BR099119 | NOVARTIS | 86.58 | YR | F | Y | 65.00000 | KG | 20160802 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125736542 | 12573654 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG, Q12MO (2 YEARS AGO) | 21817 | 5 | MG | SOLUTION FOR INJECTION | |||||||
| 125736542 | 12573654 | 2 | C | EXODUS//ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 125736542 | 12573654 | 3 | C | CALCIUM | CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 125736542 | 12573654 | 4 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 1 DF, QD (MORE THAN 10 YEARS AGO) | 0 | 1 | DF | QD | |||||||
| 125736542 | 12573654 | 5 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 2 DF, QD ( MORE THAN 10 YEARS AGO) | 0 | 2 | DF | QD | |||||||
| 125736542 | 12573654 | 6 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 125736542 | 12573654 | 7 | C | AEROLIN | ALBUTEROL | 1 | Respiratory (inhalation) | MORE THAN 10 YEARS AGO, QID | 0 | QID | |||||||||
| 125736542 | 12573654 | 8 | C | AEROLIN | ALBUTEROL | 1 | Respiratory (inhalation) | 1 DF, QD | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125736542 | 12573654 | 1 | Osteoporosis |
| 125736542 | 12573654 | 2 | Depression |
| 125736542 | 12573654 | 3 | Osteoporosis |
| 125736542 | 12573654 | 4 | Chronic obstructive pulmonary disease |
| 125736542 | 12573654 | 5 | Chronic obstructive pulmonary disease |
| 125736542 | 12573654 | 7 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125736542 | 12573654 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125736542 | 12573654 | Eating disorder | |
| 125736542 | 12573654 | Pneumonia | |
| 125736542 | 12573654 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125736542 | 12573654 | 1 | 20140721 | 0 |